Brett A. King, MD, PhD

NEA Approved Features

12/04/2018

Carlos G. Wambier, MD, PhD

JAK inhibitors appear to be effective for the treatment of AD, and this class of medications will influence the current paradigm of AD management.

JAK inhibitors appear to be...

12/04/2018

The Dermatologist

October 26 ⁠–⁠ October 27

October 29 ⁠–⁠ November 2

November 1 ⁠–⁠ November 2

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24